Direkt zum Inhalt
Merck

Fortfahren mit

I9764

Anti-Human IgG (γ-chain specific) antibody produced in rabbit

IgG fraction of antiserum, buffered aqueous solution

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Über diesen Artikel

UNSPSC Code:
12352203
NACRES:
NA.46
MDL number:
Conjugate:
unconjugated
Clone:
polyclonal
Application:
ELISA (i), IEP, QPA
Citations:
11


biological source

rabbit

Quality Level

conjugate

unconjugated

antibody form

IgG fraction of antiserum

antibody product type

secondary antibodies

clone

polyclonal

form

buffered aqueous solution

technique(s)

immunoelectrophoresis: suitable, indirect ELISA: 1:50,000, quantitative precipitin assay: 2.0-3.0 mg/mL

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

General description

IgG (immunoglobulin G) antibody subtype is a predominant serum immunoglobulins of the immune system. It is secreted by B cells and is found in blood and extracellular fluids. IgG is found in four subclasses IgG1, IgG2, IgG3 and IgG4. IgG has a monomeric structure.

Application

Anti-Human IgG (γ-chain specific) antibody produced in rabbit has been used in western blotting.
Anti-Human IgG (γ-chain specific) antibody produced in rabbit was conjugated with BSA and coated over a nanofibrillar cellulose film to develop a platform for immunoassays and diagnostics.

Biochem/physiol Actions

IgG (immunoglobulin G) antibody participates in complement fixation and opsonization.
IgG antibody subtype provides protection from infections caused by bacteria, fungi and viruses. Maternal IgG is transferred to fetus through the placenta that is vital for immune defense of the neonate against infections.

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide as preservative

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
I2011R5506B1395
antibody form

IgG fraction of antiserum

antibody form

IgG fraction of antiserum

antibody form

IgG fraction of antiserum

antibody form

IgG fraction of antiserum

conjugate

unconjugated

conjugate

unconjugated

conjugate

unconjugated

conjugate

unconjugated

biological source

rabbit

biological source

rabbit

biological source

goat

biological source

rabbit

technique(s)

immunoelectrophoresis: suitable, quantitative precipitin assay: 2.0-3.0 mg/mL, indirect ELISA: 1:50,000

technique(s)

indirect ELISA: 1:80,000, quantitative precipitin assay: 3.0-4.0 mg/mL

technique(s)

indirect ELISA: 1:30,000, quantitative precipitin assay: 3.0-4.5 mg/mL

technique(s)

indirect ELISA: 1:150,000, quantitative precipitin assay: 2.0 mg/mL

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice


Still not finding the right product?

Explore all of our products under

oder

Probieren Sie unser Produkt-Auswahlhilfe, um Ihre Auswahl einzugrenzen


Lagerklasse

10 - Combustible liquids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable



Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen


Verwandter Inhalt

Instructions


Protein disulfide isomerase does not control recombinant IgG4 productivity in mammalian cell lines
Hayes NVL, et al.
Biotechnology and Bioengineering, 105(4), 770-779 (2010)
Comparison of antibody molecules produced from two cell lines with contrasting productivities and aggregate contents
Ishii Y, et al.
Biological & Pharmaceutical Bulletin, b14-00729 (2014)
James D Budge et al.
Data in brief, 29, 105217-105217 (2020-02-20)
The data presented in this article relates to the manuscript entitled 'Engineering of Chinese hamster ovary cell lipid metabolism results in an expanded ER and enhanced recombinant biotherapeutic protein production', published in the Journal Metabolic Engineering [1]. In the article



Global Trade Item Number

SKUGTIN
I9764-2ML04061833865781

Questions

Reviews

No rating value

Active Filters